Abstract. A well described interaction between an antibradycardia pacemaker and a ventricular de®brillator is sensing of pacemaker stimuli by the ventricular de®brillator. This report describes an interaction between an atrial demand pacemaker and a ventricular de®brillator that resulted in ventricular asystole and polymorphic ventricular tachycardia. In this case, the ventricular de®brillator sensed atrial pacing stimuli when complete atrioventricular block with a slow ventricular escape rate developed. De®brillator-based ventricular demand pacing was inhibited, resulting in prolonged periods of ventricular asystole, polymorphic ventricular tachycardia, and multiple de®brillator shocks. Ventricular de®brillator sensing of atrial pacemaker stimuli in the setting of complete atrioventricular block and ventricular asystole cannot be simulated during de®brillator implantation when atrioventricular conduction is intact. Therefore, a pacemaker programmed to atrial demand pacing in a patient with a ventricular de®brillator can result in inappropriate inhibition of ventricular pacing in the setting of complete heart block. Furthermore, this interaction can be avoided with a dual-chamber pacing ventricular de®brillator.
Introduction
In the era of ventricular de®brillators with rateresponsive dual-chamber pacing, implantation of a single chamber ventricular de®brillator might still be considered in a patient with a preexisting rate-responsive pacemaker system or in a patient in whom battery longevity is a critical issue. Numerous adverse interactions in patients with a pacemaker and a ventricular de®brillator have been described [1±3] . This report describes an interaction between an atrial demand pacemaker and a ventricular de®brillator that occurred in a patient in whom complete atrioventricular block with prolonged periods of ventricular asystole developed and resulted in sustained polymorphic ventricular tachycardia.
Case Report
A 73 year old woman was admitted to an outside hospital with a chief complaint of multiple ventricular de®brillator discharges. The patient had a past medical history of coronary artery disease, myocardial infarction, diabetes mellitus, rheumatic disease of the mitral and tricuspid valves, congestive heart failure, and a left ventricular ejection fraction of 0.35. Eight years prior to admission an epicardial ventricular de®brillator system was implanted for syncope and ventricular tachycardia. Two weeks later, she developed sinus bradycardia, long-short sequences, and polymorphic ventricular tachycardia which resulted in multiple de®brillator shocks. The patient was treated with an atrial demand pacemaker. Four years later, the ventricular de®bril-lator and the pacemaker systems became infected and were explanted. After an appropriate course of antibiotic therapy, a de®brillator lead (Guidant, St. Paul MN, model 0072) was positioned in the patient's right ventricular apex and attached to a ventricular de®brillator pulse generator (Guidant, model 1746). An atrial pacemaker lead (Guidant, model 4269) was positioned in the right atrial appendage and connected to a bipolar SSI pacemaker pulse generator (Guidant, model 446). Intraoperatively, sensing of the atrial pacemaker stimulus by the ventricular de®bril-lator was observed at an amplitude of 3.75 V with a pulse width of 0.4 ms. The atrial pacemaker stimulus was not sensed at an amplitude of 2.5 V and a pulse width of 0.6 ms. The ventricular de®brillator sensed ventricular ®brillation when the pacemaker was programmed to asynchronous atrial pacing with an amplitude of 2.5 V and a pulse width of 0.6 ms. The pacemaker was chronically programmed to the AAI mode with an amplitude of 2.5 V and a pulse width of 0.6 ms. Amiodarone at a daily dosage of 200 mg was initiated subsequently for atrial ®brillation.
Interrogation of the patient's ventricular de®-brillator upon presentation to the University of Michigan Medical Center demonstrated 19 episodes of polymorphic ventricular tachycardia, 12 of which were sustained and resulted in shocks. During AAI pacing at 85 beats per minute, the patient developed complete atrioventricular block (Fig. 1) . The ventricular de®brilla-tor sensed pacing stimuli from the atrial pacemaker which inhibited VVI pacing. Longshort sequences occurred, and polymorphic ventricular tachycardia resulted. Normal postshock VVI pacing was observed (Fig. 1) . However, after non-sustained episodes of polymorphic ventricular tachycardia with diverted shocks, the ventricular de®brillator sensed the atrial pacing stimuli, de®brillator-based VVI pacing was inhibited, and ventricular asystole resulted (Fig. 2) .
Programmed settings for the atrial pacemaker were AAI pacing at 85 beats per minute with an output amplitude of 2.5 V with a pulse width of 0.6 ms. The pacemaker was immediately deactivated and the ventricular de®brillator's VVI pacing rate was increased to 85 beats per minute. Amiodarone, desethylamiodarone and digoxin concentrations were 1.1 mgaml, 0.9 mgaml, and 1.7 ngaml, respectively. Within hours of discontinuing amiodarone and digoxin, atrioventricular conduction resumed. The patient received a DDDR ventricular de®brillator 8 days later without complication.
Discussion

Main Finding
Oversensing of atrial pacemaker stimuli by a ventricular de®brillator, with subsequent inhibition of de®brillator-based VVI pacing in the setting of atrioventricular block, has not been described as a pacemaker±de®brillator interaction.
Mechanism
The pacemaker±de®brillator interaction described herein is most likely due to the de®b-rillator's capability to automatically adjust sensitivity. These sensing ampli®ers and algorithms differ among different companies. In our case, after a sensed event, the de®brillator automatically adjusted the sensitivity to 75% of the amplitude of the sensed signal. After the ventricular refractory period, the sensitivity doubled every 156 ms until either a signal was sensed or the maximum sensitivity was reached. In this patient, an atrial pacemaker stimulus was not sensed by the de®brillator immediately after the onset of complete atrioventricular block. Without sensed ventricular events, the de®brillator's sensitivity increased such that the next atrial pacing stimulus was sensed. Since the ventricular escape interval was programmed to 1500 ms, which was much longer than the atrial escape interval of 706 ms, de®brillator-based ventricular demand pacing was continuously inhibited. This resulted in severe bradycardia and polymorphic ventricular tachycardia. Post-shock VVI pacing, in contrast, occurred with a ®xed sensitivity of 2.5 mV, which was inadequate for sensing atrial pacing stimuli. However, after a nonsustained episode of polymorphic ventricular tachycardia, the sensitivity remained at maximum, the atrial stimuli were sensed, and de®brillator-based VVI pacing was inhibited.
Previous Studies
Numerous reports indicate that implantation of a de®brillator and a separate pacemaker is safe if intraoperative testing fails to demonstrate oversensing or undersensing [4±6] . For instance, sensing of a pacemaker stimulus during ventricular ®brillation may lead to inhibition of ventricular ®brillation therapy [1] . Conversely, sensing of the pacemaker stimulus and the associated evoked potential may lead to inappropriate shocks [7±9]. 
Clinical Implications
Based on this case report, previously described pacemaker-de®brillator interactions can be safely excluded during intraoperative testing only if the pacemaker is programmed to a mode that incorporates ventricular sensing. As many as 12% of patients with normal AV-conduction at the time of AAI pacemaker implantation will develop second or third degree AV block [10] . This report highlights the potential for serious device interactions in patients with a de®brillator and pacemaker-based AAI pacing. This interaction can be avoided with a dual-chamber pacing ventricular de®brillator.
